CERS Cerus Corp

Price (delayed)

$5.76

Market cap

$985.95M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.36

Enterprise value

$1.01B

Sector: Healthcare
Industry: Biotechnology

Highlights

CERS's EPS is up by 25% year-on-year and by 2.7% since the previous quarter
CERS's revenue is up by 24% year-on-year and by 4.3% since the previous quarter
The quick ratio has declined by 18% year-on-year but it rose by 6% since the previous quarter
Cerus's debt has increased by 29% YoY and by 24% QoQ
CERS's equity is down by 18% year-on-year and by 11% since the previous quarter

Key stats

What are the main financial stats of CERS
Market
Shares outstanding
171.17M
Market cap
$985.95M
Enterprise value
$1.01B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
10.46
Price to sales (P/S)
8.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.47
Earnings
Revenue
$119.17M
EBIT
-$56.74M
EBITDA
-$52.14M
Free cash flow
-$40.27M
Per share
EPS
-$0.36
Free cash flow per share
-$0.24
Book value per share
$0.55
Revenue per share
$0.71
TBVPS
$1.3
Balance sheet
Total assets
$220.58M
Total liabilities
$127.95M
Debt
$82.74M
Equity
$92.64M
Working capital
$126.51M
Liquidity
Debt to equity
0.89
Current ratio
3.31
Quick ratio
2.78
Net debt/EBITDA
-0.44
Margins
EBITDA margin
-43.7%
Gross margin
63.1%
Net margin
-51.1%
Operating margin
-49.8%
Efficiency
Return on assets
-27.9%
Return on equity
-57.9%
Return on invested capital
-29.4%
Return on capital employed
-34.2%
Return on sales
-47.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CERS stock price

How has the Cerus stock price performed over time
Intraday
3.78%
1 week
-6.19%
1 month
-7.4%
1 year
10.34%
YTD
-16.76%
QTD
-4.16%

Financial performance

How have Cerus's revenue and profit performed over time
Revenue
$119.17M
Gross profit
$75.24M
Operating income
-$59.38M
Net income
-$60.85M
Gross margin
63.1%
Net margin
-51.1%
Cerus's net margin has increased by 29% YoY and by 2.5% QoQ
Cerus's operating margin has increased by 27% YoY and by 2.5% QoQ
CERS's revenue is up by 24% year-on-year and by 4.3% since the previous quarter
The company's gross profit rose by 19% YoY and by 2.9% QoQ

Growth

What is Cerus's growth rate over time

Valuation

What is Cerus stock price valuation
P/E
N/A
P/B
10.46
P/S
8.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.47
CERS's EPS is up by 25% year-on-year and by 2.7% since the previous quarter
CERS's equity is down by 18% year-on-year and by 11% since the previous quarter
CERS's price to book (P/B) is 5% higher than its 5-year quarterly average of 9.6 but 2.1% lower than its last 4 quarters average of 10.3
CERS's revenue is up by 24% year-on-year and by 4.3% since the previous quarter
The stock's price to sales (P/S) is 24% less than its 5-year quarterly average of 10.3 and 19% less than its last 4 quarters average of 9.7

Efficiency

How efficient is Cerus business performance
CERS's return on equity is up by 38% year-on-year but it is down by 6% since the previous quarter
CERS's return on sales is up by 29% year-on-year and by 2.7% since the previous quarter
Cerus's return on assets has increased by 27% YoY
The ROIC has grown by 26% YoY but it has contracted by 2.8% from the previous quarter

Dividends

What is CERS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CERS.

Financial health

How did Cerus financials performed over time
CERS's total assets is 72% greater than its total liabilities
Cerus's total liabilities has increased by 24% YoY and by 9% QoQ
The quick ratio has declined by 18% year-on-year but it rose by 6% since the previous quarter
Cerus's debt is 11% lower than its equity
Cerus's debt to equity has surged by 56% YoY and by 39% QoQ
Cerus's debt has increased by 29% YoY and by 24% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.